U.S. Banks Stock News

Immuneering (IMRX) is back on traders’ screens after releasing updated Phase 2a data for atebimetinib plus modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer, showing higher overall survival and response metrics than standard benchmarks. See our latest analysis for Immuneering. The updated atebimetinib data arrive after a tough recent stretch, with the share price at US$4.73 and a 1 day share price return of 43.22% decline. However, a 1 year total shareholder return of 136.5%...

If you are wondering whether Comerica's share price still offers value after a strong run, this review will help you separate sentiment from what the numbers suggest. Comerica's stock last closed at US$92.56, with returns of 6.5% over 7 days, 10.5% over 30 days, 4.4% year to date, 55.1% over 1 year, 57.3% over 3 years and 76.8% over 5 years. Recent market attention on U.S. regional banks has kept Comerica in focus, as investors reassess how interest rate expectations and credit conditions...

CureVac N.V. recently closed its August 14, 2020 shelf registration in the amount of €3.21 million, covering 26,768,980 common shares for an ESOP-related offering. A day earlier, CureVac was removed from the NASDAQ Composite Index, a change that can influence trading behavior as index-tracking investors rebalance their holdings. We will now examine how CureVac’s removal from the NASDAQ Composite Index may influence its pre-existing investment narrative and risk profile. Uncover the next big...

If you are wondering whether Resideo Technologies is priced attractively or already baking in high expectations, you are in the right place. The stock last closed at US$36.86, with returns of 5.0% over 7 days, 9.8% over 30 days, 4.8% year to date, 63.4% over 1 year, 98.2% over 3 years, and 44.5% over 5 years, which raises fair questions about how much value is now reflected in the share price. Recent coverage has focused on Resideo's position in residential comfort, security and energy...

If you are wondering whether Cadence Bank's current share price offers good value or not, you are in the right place because this article focuses squarely on what investors may be paying for today. Cadence Bank's stock has recently closed at US$45.67, with returns of 6.6% over 7 days, 9.7% over 30 days, 5.7% year to date, 34.3% over 1 year and 76.9% over 5 years. This raises questions about how much of this performance is already reflected in the price. Recent attention on Cadence Bank has...

Anywhere Real Estate: Recent Performance Snapshot Anywhere Real Estate (HOUS) has been catching investor attention after a sharp move in its share price, with recent returns standing at 3.6% over the past day and 24.6% across the past week. Those short term gains sit alongside a month return of 20% and an approximately 87% move over the past 3 months, putting the current share price at US$17.64 as of the latest close. See our latest analysis for Anywhere Real Estate. Looking beyond the recent...

Oncology Institute (TOI) recently drew fresh investor attention after announcing that Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, joined its Board of Directors, bringing additional healthcare and public markets experience. See our latest analysis for Oncology Institute. The board appointment comes as Oncology Institute’s share price has gained momentum, with a 21.1% 7 day share price return and a strong 1 year total shareholder return, although the 5 year...

If you are wondering whether PAR Technology at around US$37.19 is priced attractively or not, you are in the right place for a clear look at what that tag might actually represent. The stock has seen mixed returns, with gains of 2.5% over the last week, 4.6% over the last month and 4.1% year to date, set against a 45.4% decline over the past year and 46.9% over five years. This raises questions about how the market currently views its risk and potential. Recent attention around PAR...

Jefferies Financial Group (JEF) has wrapped up FY 2025 with fourth quarter revenue of US$2.1 billion and net income from continuing operations of US$195.3 million, while earnings from discontinued operations came in at a loss of US$4.4 million. The company has seen quarterly revenue move from US$1.96 billion in Q4 2024 to US$2.07 billion in Q4 2025, and trailing 12 month net income from continuing operations sit at US$635.2 million. This sets the backdrop for how investors weigh the latest...

If you are wondering whether Kodiak Sciences' share price still reflects its true worth after a strong run, this article walks through what the current valuation might be telling you. The stock closed at US$27.07, with returns of 3.6% over 30 days, 4.0% year to date and 194.2% over the last year, alongside a 3.2% decline over the past week and a 236.7% gain across three years, compared with an 82.4% decline over five years. Recent coverage around Kodiak Sciences has centered on its position...

Quest Diagnostics Incorporated ( NYSE:DGX ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is...

Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 34.9x might make it look like a strong sell...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

As the U.S. stock market experiences mixed signals with major indices like the Dow Jones climbing while the Nasdaq faces pressure from data-storage shares, investors are keenly observing sectors and stocks that might offer value amidst this volatility. In such a climate, identifying undervalued stocks can be particularly appealing, as they present opportunities to capitalize on potential price corrections when broader economic conditions stabilize or improve.

Major stock indexes in the United States are showing mixed performance, with the Dow Jones Industrial Average rising while data-storage shares weigh on the Nasdaq. For investors willing to explore beyond established giants, penny stocks—often representing smaller or newer companies—offer intriguing opportunities. Despite their vintage name, these stocks can present underappreciated growth potential at lower price points, especially when backed by strong balance sheets and solid fundamentals.

In a market where major stock indexes are showing mixed results, with the Dow Jones Industrial Average rising and the Nasdaq being pulled down by data-storage shares, investors are keenly observing small-cap opportunities as potential growth drivers. With the services sector expanding and manufacturing struggling, uncovering promising small-cap stocks can be a strategic move in navigating these dynamic economic conditions.

The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by...

If you are wondering whether TIC Solutions at around US$9.99 is a bargain or a value trap, you are in the right place to get a clear, valuation led view. The share price has seen mixed returns, with a 1.2% decline over the last 7 days, a 5.3% gain over 30 days, and a 16.7% decline over the past year. These moves can change how investors think about both upside and risk. Recent coverage of TIC Solutions has focused on its share price performance over different time frames and how investors...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

In its most recent quarter, Pacific Biosciences of California reported strong uptake of its Revio and Vega sequencing platforms and launched the SPRQ-Nx chemistry, which lowers long-read sequencing costs and broadens clinical research applications through its PureTarget portfolio. An important angle is that many recent system placements came from first-time customers, meaning the company is expanding its installed base rather than relying solely on existing users. We’ll now examine how the...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

ZipRecruiter, Inc.'s (NYSE:ZIP) stock price has dropped 10.0% in the previous week, but insiders who sold US$887k in...

Precigen, Inc. ( NASDAQ:PGEN ) is possibly approaching a major achievement in its business, so we would like to shine...